These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Fukatsu S, Yano I, Igarashi T, Hashida T, Takayanagi K, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K, Tanaka K, Inui K. Eur J Clin Pharmacol; 2001 Sep; 57(6-7):479-84. PubMed ID: 11699612 [Abstract] [Full Text] [Related]
4. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Sam WJ, Tham LS, Holmes MJ, Aw M, Quak SH, Lee KH, Lim SG, Prabhakaran K, Chan SY, Ho PC. Clin Pharmacokinet; 2006 Sep; 45(1):59-75. PubMed ID: 16430311 [Abstract] [Full Text] [Related]
5. Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation. Fukudo M, Yano I, Shinsako K, Katsura T, Takada Y, Uemoto S, Inui K. J Clin Pharmacol; 2009 Jul; 49(7):789-97. PubMed ID: 19487492 [Abstract] [Full Text] [Related]
6. Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period. Kato H, Usui M, Muraki Y, Okuda M, Nakatani K, Hayasaki A, Ito T, Iizawa Y, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Isaji S. Transplant Proc; 2018 Nov; 50(9):2684-2689. PubMed ID: 30401377 [Abstract] [Full Text] [Related]
7. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet? Brooks E, Tett SE, Isbel NM, Staatz CE. Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787 [Abstract] [Full Text] [Related]
8. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Willis C, Staatz CE, Tett SE. Ther Drug Monit; 2003 Apr; 25(2):158-66. PubMed ID: 12657909 [Abstract] [Full Text] [Related]
9. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE. Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506 [Abstract] [Full Text] [Related]
10. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance. Wallin JE, Bergstrand M, Wilczek HE, Nydert PS, Karlsson MO, Staatz CE. Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583 [Abstract] [Full Text] [Related]
11. External validation of population pharmacokinetic models of tacrolimus in Thai adult liver transplant recipients. Komenkul V, Sukarnjanaset W, Komolmit P, Wattanavijitkul T. Eur J Clin Pharmacol; 2024 Aug; 80(8):1229-1240. PubMed ID: 38695888 [Abstract] [Full Text] [Related]
12. Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation. Nakagawa J, Ishido K, Tono Y, Kimura N, Wakiya T, Okamura Y, Hakamada K, Niioka T. Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):619-626. PubMed ID: 32514937 [Abstract] [Full Text] [Related]
13. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. Staatz CE, Tett SE. Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452 [Abstract] [Full Text] [Related]
14. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance. Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S. Eur J Clin Pharmacol; 2005 Jul; 61(5-6):409-16. PubMed ID: 15991041 [Abstract] [Full Text] [Related]
15. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Staatz CE, Willis C, Taylor PJ, Tett SE. Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747 [Abstract] [Full Text] [Related]
16. Pharmacokinetics and Pharmacodynamics of Once-Daily Tacrolimus Compared With Twice-Daily Tacrolimus in the Early Stage After Living Donor Liver Transplantation. Iwasaki M, Yano I, Fukatsu S, Hashi S, Yamamoto Y, Sugimoto M, Fukudo M, Masuda S, Nakagawa S, Yonezawa A, Kaido T, Uemoto S, Matsubara K. Ther Drug Monit; 2018 Dec; 40(6):675-681. PubMed ID: 29965882 [Abstract] [Full Text] [Related]
17. A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting. Charpiat B, Falconi I, Bréant V, Jelliffe RW, Sab JM, Ducerf C, Fourcade N, Thomasson A, Baulieux J. Ther Drug Monit; 1998 Apr; 20(2):158-64. PubMed ID: 9558129 [Abstract] [Full Text] [Related]
18. Predictive Performance of Published Tacrolimus Population Pharmacokinetic Models in Thai Kidney Transplant Patients. Methaneethorn J, Lohitnavy M, Onlamai K, Leelakanok N. Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):105-116. PubMed ID: 34817826 [Abstract] [Full Text] [Related]
19. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, Everson GT. Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565 [Abstract] [Full Text] [Related]
20. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients. Song GW, Lee SG, Hwang S, Kim KH, Kim WJ, Sin MH, Yoon YI, Tak EY. Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646 [Abstract] [Full Text] [Related] Page: [Next] [New Search]